Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Hepatocellular × Afatinib × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 37 Neoplasms 10 Breast Neoplasms 10 Head and Neck Neoplasms 5 Lung Neoplasms 3 Carcinoma, Squamous Cell 3 Adenocarcinoma 3 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Lymphoma 2 Urologic Neoplasms 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Thoracic Neoplasms 1 Squamous Non-small Cell Lung Cancer 1 Squamous Cell Cancers of the Head and Neck 1 Rhabdomyosarcoma 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Prostatic Neoplasms 1 Pleural Neoplasms 1 Pleural Effusion, Malignant 1 Pleural Effusion 1 Pleural Diseases 1 Neuroectodermal Tumors 1 Neoplasms by Site 1 Lung Diseases 1

Interventions

Sorafenib 52 pembrolizumab 25 Nivolumab 19 Bevacizumab 19 Radiosurgery 17 Doxorubicin 12 atezolizumab 9 Erlotinib Hydrochloride 9 lenvatinib 8 cabozantinib 6 Ramucirumab 6 Radiofrequency Ablation 6 Magnetic Resonance Spectroscopy 6 Cisplatin 6 tremelimumab 5 durvalumab 5 Sunitinib 5 tislelizumab 4 regorafenib 4 Oxaliplatin 4 Leucovorin 4 Ipilimumab 4 Fluorouracil 4 Everolimus 4 Capecitabine 4 nintedanib 3 fluoromisonidazole 3 carotuximab 3 bavituximab 3 Tomography, X-Ray Computed 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡